[go: up one dir, main page]

PT969816E - Preparacao de aglomerados de po - Google Patents

Preparacao de aglomerados de po

Info

Publication number
PT969816E
PT969816E PT98911423T PT98911423T PT969816E PT 969816 E PT969816 E PT 969816E PT 98911423 T PT98911423 T PT 98911423T PT 98911423 T PT98911423 T PT 98911423T PT 969816 E PT969816 E PT 969816E
Authority
PT
Portugal
Prior art keywords
boxes
preparation
Prior art date
Application number
PT98911423T
Other languages
English (en)
Inventor
Tsong-Toh Yang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25232603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT969816(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT969816E publication Critical patent/PT969816E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT98911423T 1997-03-20 1998-03-16 Preparacao de aglomerados de po PT969816E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82112997A 1997-03-20 1997-03-20

Publications (1)

Publication Number Publication Date
PT969816E true PT969816E (pt) 2005-04-29

Family

ID=25232603

Family Applications (2)

Application Number Title Priority Date Filing Date
PT03020466T PT1393721E (pt) 1997-03-20 1998-03-16 Forma de dosagem de aglomerados de pó
PT98911423T PT969816E (pt) 1997-03-20 1998-03-16 Preparacao de aglomerados de po

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT03020466T PT1393721E (pt) 1997-03-20 1998-03-16 Forma de dosagem de aglomerados de pó

Country Status (25)

Country Link
EP (3) EP0969816B1 (pt)
JP (5) JP3901738B2 (pt)
KR (1) KR100386055B1 (pt)
CN (3) CN100518718C (pt)
AR (1) AR011986A1 (pt)
AT (2) ATE284677T1 (pt)
AU (1) AU741783B2 (pt)
CA (3) CA2706634C (pt)
CL (1) CL2011000050A1 (pt)
CZ (1) CZ295460B6 (pt)
DE (2) DE69828155T2 (pt)
DK (2) DK1393721T3 (pt)
ES (2) ES2316681T3 (pt)
HU (2) HU226671B1 (pt)
ID (1) ID24472A (pt)
IL (1) IL131640A0 (pt)
MY (1) MY120725A (pt)
NO (1) NO328062B1 (pt)
NZ (1) NZ337443A (pt)
PL (3) PL192441B1 (pt)
PT (2) PT1393721E (pt)
SK (1) SK284919B6 (pt)
TW (1) TWI221778B (pt)
WO (1) WO1998041193A1 (pt)
ZA (1) ZA982254B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723985D0 (en) * 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
SE9804001D0 (sv) 1998-11-23 1998-11-23 Astra Ab New process
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
CA2382216A1 (en) * 1999-08-20 2001-03-01 Xian Ming Zeng Method to produce powders for pulmonary or nasal administration
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
GB0009609D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic compositions
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
FI20002177A0 (fi) * 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ITMI20012174A1 (it) * 2001-10-18 2003-04-18 Univ Parma Polvere per somministrazione nasale di farmaci
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
JP2007501194A (ja) * 2003-08-05 2007-01-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドとβ模倣薬を含む吸入用薬剤
DE60325906D1 (de) 2003-08-08 2009-03-05 Amgen Fremont Inc Antikörper gegen parath-hormon (pth) und ihre verwendungen
US7318925B2 (en) 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
CA2540005A1 (en) * 2003-09-26 2005-04-07 Schering Corporation Pulmonary disease treatment
US20070053843A1 (en) * 2003-10-28 2007-03-08 Dawson Michelle L Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
EP1691786A1 (en) * 2003-12-04 2006-08-23 Pfizer Products Inc. Multiparticulate compositions with improved stability
SI1691787T1 (sl) * 2003-12-04 2008-10-31 Pfizer Prod Inc Postopek za pripravo farmacevtskih produktov iz več delcev
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102006030166A1 (de) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tempern
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
TW201024034A (en) 2008-12-30 2010-07-01 Saint Gobain Abrasives Inc Bonded abrasive tool and method of forming
EP2421514A2 (en) * 2009-04-24 2012-02-29 Schering Corporation Agglomerate formulations useful in dry powder inhalers
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PL2435024T3 (pl) 2009-05-29 2017-01-31 Pearl Therapeutics, Inc. Dostarczanie substancji czynnych do dróg oddechowych oraz powiązane sposoby i systemy
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
HRP20180488T1 (hr) * 2010-04-21 2018-07-13 Chiesi Farmaceutici S.P.A. Postupak priprave čestica sa smanjenim elektrostatičkim nabojem
CA2905542C (en) 2013-03-15 2022-05-03 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
JP6020489B2 (ja) 2014-02-27 2016-11-02 トヨタ自動車株式会社 昇圧コンバータ及びその制御方法
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
EP3400214B1 (en) * 2016-01-08 2024-03-13 Theron Pharmaceuticals, Inc. Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives
CN117122585A (zh) * 2023-07-27 2023-11-28 宁波诺丁汉大学 一种通过振动混合制备干粉吸入团聚物处方制剂方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
DE59100388D1 (de) * 1990-01-29 1993-10-28 Ciba Geigy Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers.
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
DK0613371T3 (da) * 1991-12-18 2002-05-13 Astrazeneca Ab Ny kombination af formoterol og budesonid
JP2924924B2 (ja) * 1992-12-18 1999-07-26 シェリング・コーポレーション 粉末薬物のための吸入器
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
PT721331E (pt) * 1993-10-01 2002-05-31 Astrazeneca Ab Processo i
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
ES2197212T3 (es) * 1994-12-22 2004-01-01 Astrazeneca Ab Preparacion terapeutica para inhalacion que contiene la hormona paratiroidea, pth.

Also Published As

Publication number Publication date
CA2282360A1 (en) 1998-09-24
CA2481868C (en) 2010-06-15
DK1393721T3 (da) 2009-03-30
NO328062B1 (no) 2009-11-13
TWI221778B (en) 2004-10-11
CA2481868A1 (en) 1998-09-24
JP2010248260A (ja) 2010-11-04
CA2706634A1 (en) 1998-09-24
HU230274B1 (hu) 2015-11-30
HU226671B1 (en) 2009-06-29
IL131640A0 (en) 2001-01-28
EP1393721B1 (en) 2008-11-26
DK0969816T3 (da) 2005-03-14
PL208480B1 (pl) 2011-05-31
PT1393721E (pt) 2009-02-02
EP0969816A1 (en) 2000-01-12
EP2036544A1 (en) 2009-03-18
MY120725A (en) 2005-11-30
CZ295460B6 (cs) 2005-08-17
CA2706634C (en) 2012-10-23
JP3901738B2 (ja) 2007-04-04
EP2036544B1 (en) 2016-12-28
NO994519L (no) 1999-11-19
ATE415149T1 (de) 2008-12-15
AU6537898A (en) 1998-10-12
KR100386055B1 (ko) 2003-06-09
ES2234102T3 (es) 2005-06-16
AR011986A1 (es) 2000-09-13
CN1903179A (zh) 2007-01-31
HK1021323A1 (en) 2000-06-09
PL192441B1 (pl) 2006-10-31
JP2010275316A (ja) 2010-12-09
HK1061359A1 (en) 2004-09-17
CN100518718C (zh) 2009-07-29
SK284919B6 (sk) 2006-02-02
CN100548277C (zh) 2009-10-14
ID24472A (id) 2000-07-20
DE69828155T2 (de) 2005-12-22
KR20010005520A (ko) 2001-01-15
CL2011000050A1 (es) 2011-06-24
DE69828155D1 (de) 2005-01-20
NO994519D0 (no) 1999-09-17
CA2282360C (en) 2004-11-09
HU0600845D0 (en) 2007-01-29
HUP0002029A2 (hu) 2000-11-28
JP2006152000A (ja) 2006-06-15
PL335742A1 (en) 2000-05-08
CZ323399A3 (cs) 2000-02-16
AU741783B2 (en) 2001-12-06
DE69840277D1 (de) 2009-01-08
ATE284677T1 (de) 2005-01-15
CN1149076C (zh) 2004-05-12
CN1257423A (zh) 2000-06-21
PL204480B1 (pl) 2010-01-29
JP5523240B2 (ja) 2014-06-18
NZ337443A (en) 2001-04-27
ZA982254B (en) 1998-09-17
WO1998041193A1 (en) 1998-09-24
CN1552310A (zh) 2004-12-08
JP2014037446A (ja) 2014-02-27
HUP0002029A3 (en) 2001-02-28
EP1393721A1 (en) 2004-03-03
EP0969816B1 (en) 2004-12-15
JP2000510478A (ja) 2000-08-15
ES2316681T3 (es) 2009-04-16
SK128099A3 (en) 2000-06-12

Similar Documents

Publication Publication Date Title
PT969816E (pt) Preparacao de aglomerados de po
PT891776E (pt) Composicoes de simeticona/fosfato de calcio anidro
IS2325B (is) Örgerðar samsetningar epleróns
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
ID27092A (id) Pembuatan ftalat anhidrida
EP0968223A4 (en) BIOKON JUGATION OF MACROMOLECULES
PT877070E (pt) Fosforo fotossensivel
PT945132E (pt) Composicao de ibuprofeno
PT973527E (pt) Formulacoes de libertacao prolongada de claritromicina
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
IS5536A (is) Efnablanda fyrir snyrtivörur
PT1028718E (pt) Formulacao de libertacao prolongada
DE59810991D1 (de) Phosphorsäurealkylester
PT866179E (pt) Caixa de distribuicao
EP0885896A4 (en) PHOSPHOLIPIDE COMPOSITION
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
PT906101E (pt) Formulacoes farmaceuticas de libertacao prolongada contendo mizolastina
DE69828796D1 (de) Hochreine verzweigte alkylsilsesquioxanflüssigkeiten
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
FR2766600B1 (fr) Boitier de telereport
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
EP1005474A4 (en) Production of polyorganophosphazenes
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
FR2763940B1 (fr) Preparation de trifluoromethoxy-2-aniline